Literature DB >> 19753922

Clostridium difficile infection: a re-emerging threat.

Hitoshi Honda1, Erik R Dubberke.   

Abstract

Clostridium difficile infection is an important health care-associated infection. The incidence and severity of C. difficile infection are increasing. Recent C. difficile infection outbreaks with high proportions of severe outcomes have been linked to an emerging, hypervirulent strain of C. difficile. Recently recognized risk factors of C. difficile infection include fluoroquinolone exposure and gastric acid suppression. Effective prevention measures for C. difficile infection include contact precautions and antimicrobial stewardship. Awareness of C. difficile infection is critical to provide appropriate clinical care.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19753922      PMCID: PMC3648223     

Source DB:  PubMed          Journal:  Mo Med        ISSN: 0026-6620


  29 in total

1.  Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec.

Authors:  Jacques Pépin; Louis Valiquette; Benoit Cossette
Journal:  CMAJ       Date:  2005-09-22       Impact factor: 8.262

2.  Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe.

Authors:  Michel Warny; Jacques Pepin; Aiqi Fang; George Killgore; Angela Thompson; Jon Brazier; Eric Frost; L Clifford McDonald
Journal:  Lancet       Date:  2005 Sep 24-30       Impact factor: 79.321

3.  An epidemic, toxin gene-variant strain of Clostridium difficile.

Authors:  L Clifford McDonald; George E Killgore; Angela Thompson; Robert C Owens; Sophia V Kazakova; Susan P Sambol; Stuart Johnson; Dale N Gerding
Journal:  N Engl J Med       Date:  2005-12-01       Impact factor: 91.245

4.  Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease.

Authors:  Sandra Dial; J A C Delaney; Alan N Barkun; Samy Suissa
Journal:  JAMA       Date:  2005-12-21       Impact factor: 56.272

5.  Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A.

Authors:  L Kyne; M Warny; A Qamar; C P Kelly
Journal:  N Engl J Med       Date:  2000-02-10       Impact factor: 91.245

6.  Primary symptomless colonisation by Clostridium difficile and decreased risk of subsequent diarrhoea.

Authors:  J K Shim; S Johnson; M H Samore; D Z Bliss; D N Gerding
Journal:  Lancet       Date:  1998-02-28       Impact factor: 79.321

7.  Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube.

Authors:  Johannes Aas; Charles E Gessert; Johan S Bakken
Journal:  Clin Infect Dis       Date:  2003-02-14       Impact factor: 9.079

8.  Randomized controlled trial of colestipol in antibiotic-associated colitis.

Authors:  G A Mogg; R H George; D Youngs; M Johnson; H Thompson; D W Burdon; M R Keighley
Journal:  Br J Surg       Date:  1982-03       Impact factor: 6.939

9.  Outbreak of Clostridium difficile infection in a long-term care facility: association with gatifloxacin use.

Authors:  Robert Gaynes; David Rimland; Edna Killum; H Ken Lowery; Theodore M Johnson; George Killgore; Fred C Tenover
Journal:  Clin Infect Dis       Date:  2004-02-11       Impact factor: 9.079

10.  Increase in adult Clostridium difficile-related hospitalizations and case-fatality rate, United States, 2000-2005.

Authors:  Marya D Zilberberg; Andrew F Shorr; Marin H Kollef
Journal:  Emerg Infect Dis       Date:  2008-06       Impact factor: 6.883

View more
  2 in total

Review 1.  The Use of Fecal Microbiome Transplant in Treating Human Diseases: Too Early for Poop?

Authors:  Hooi-Leng Ser; Vengadesh Letchumanan; Bey-Hing Goh; Sunny Hei Wong; Learn-Han Lee
Journal:  Front Microbiol       Date:  2021-05-13       Impact factor: 5.640

2.  Gut bacterial communities of diarrheic patients with indications of Clostridioides difficile infection.

Authors:  Dominik Schneider; Andrea Thürmer; Kathleen Gollnow; Raimond Lugert; Katrin Gunka; Uwe Groß; Rolf Daniel
Journal:  Sci Data       Date:  2017-10-17       Impact factor: 6.444

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.